Tasha Jones
Gerontology · Mobile, ALNPI 1386206688
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 61 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations.
Across 61 payments — averaging $58.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$494
- AstraZeneca$405
- Novo Nordisk$376
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$250
- Axsome Therapeutics, Inc.$206
- Xeris Pharmaceuticals, Inc.$156
- plus $2K from 22 others
What the payments were for
- Food & beverage$3,597100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 8 | $494 |
| AstraZeneca(2 entities) | 4 | $405 |
| Novo Nordisk | 6 | $376 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $250 |
| Axsome Therapeutics, Inc. | 2 | $206 |
| Xeris Pharmaceuticals, Inc. | 2 | $156 |
| Johnson & Johnson(2 entities) | 3 | $146 |
| Bayer | 2 | $130 |
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| Actelion Pharmaceuticals US, Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Alnylam Pharmaceuticals Inc. | 1 | $122 |
| Gilead | 1 | $122 |
| Pfizer | 1 | $110 |
| Medtronic | 2 | $106 |
| Sanofi | 4 | $99 |
| Novartis | 4 | $86 |
| Abiomed | 1 | $80 |
| E.r. Squibb & Sons, L.L.C. | 4 | $79 |
| Stryker | 1 | $50 |
| Vertex | 1 | $45 |
| Seagen Inc. | 2 | $35 |
| AbbVie | 2 | $34 |
| Dexcom, Inc. | 1 | $24 |
| Incyte Corporation | 1 | $19 |
| Currax Pharmaceuticals LLC | 1 | $16 |
| Acrotech Biopharma Inc. | 1 | $15 |
| GSK | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$373
- CAPLYTA$250
- Auvelity$135
- GVOKE HYPOPEN$135
- QELBREE$125
- UPTRAVI$125
- OPSUMIT$125
- ABILIFY ASIMTUFII$125
- ABILIFY MAINTENA$125
- Ozempic$122
- GIVLAARI$122
- Epclusa$122
- FARXIGA$116
- ABRYSVO$110
- SPRAVATO$103
How this compares
$3,597 in reported general payments places this provider in the 80th percentile of 143 gerontology providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $308 |
Paid to pharmacies, not to this prescriber.
Other gerontology in Mobile
- Michelle SanfordMobile$11K
- Stephanie FoutsMobile$7K
- Alicia LandMobile$5K
- Krishna JefcoatMobile$2K
- Kathleen FergusonMobile$2K
- Lauren KingMobile$2K
- Amy OdomMobile$1K
- Ryan ShannonMontgomery$66K
- Claire BruceHuntsville$12K
- Virginia McNeillNorthport$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.